ÍøºìºÚÁÏ

Skip to main content

R. David Anderson, MD, MS, FACC, FACC, FSCAI, FSCAI

Cardiologist (Heart Specialist), Interventional Cardiologist, Internist

Photo of R. David Anderson

Research at a glance

Top areas of exploration

  • Myocardial Infarction , 22 publications
  • Myocardial Ischemia , 15 publications
  • Coronary Artery Disease , 14 publications
  • Coronary Circulation , 10 publications

Research activity

115 publications

7,441 citations

Why is this important?

Active clinical trials

CardiALLO-HF
Investigator
R. David Anderson
Status
Accepting Candidates
PROTECT IV

The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart…

Investigator
R. David Anderson
Status
Accepting Candidates
Ages
18 Years - 90 Years
Sexes
All
SMART

The purpose of this trial is to generate clinical evidence on valve safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) in subjects with a small aortic annulus and symptomatic…

Investigator
R. David Anderson
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

115 publications

2016

Does RIDDLE-NSTEMI Provide an Answer to the Timing of ACS Therapy?

JACC. Cardiovascular interventions

•

2016

Ixmyelocel-T for Patients With Ischaemic Heart Failure: a Prospective Randomised Double-Blind Trial

Lancet

2016

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.

Lancet (London, England)

•

2016

Renal denervation: Past, present, and future

Cardiovascular Innovations and Applications

2015

Acute kidney injury after transcatheter aortic valve replacement

American Journal of Nephrology